In: Plos one, 2012, vol. 7, no. 4, p. e35485
Based on the partial efficacy of the HIV/AIDS Thai trial (RV144) with a canarypox vector prime and protein boost, attenuated poxvirus recombinants expressing HIV-1 antigens are increasingly sought as vaccine candidates against HIV/AIDS. Here we describe using systems analysis the biological and immunological characteristics of the attenuated vaccinia virus Ankara strain expressing the HIV-1...
|
In: Clinical Infectious Diseases, 2011, vol. 52, no. 2, p. 248-256
|
In: Clinical Infectious Diseases, 2004, vol. 38, no. 3, p. 311-320
|
In: Journal of Infectious Diseases, 1994, vol. 170, no. 5, p. 1319-1322
|
In: Clinical Infectious Diseases, 2009, vol. 49, no. 5, p. 733-735
|
In: Journal of Infectious Diseases, 1995, vol. 171, no. 3, p. 639-644
|
In: The Journal of Infectious Diseases, 2013, vol. 207, no. 2, p. 331-339
|
In: Clinical Infectious Diseases, 2004, vol. 39, no. Supplement_4, p. S185-S192
|
In: Clinical Infectious Diseases, 2005, vol. 41, no. Supplement_7, p. S513-S519
|
In: Clinical Infectious Diseases, 2007, vol. 44, no. 10, p. 1321-1328
|